Abstract
In critically ill patients with acute kidney injury, high intensity continuous renal replacement therapy (CRRT) (effluent flow rate >25mL/kg/h) shows no benefit on 90-day mortality and is associated with more hypophosphataemia.
Level of evidence: 1+ (RCT with a low risk of bias)